Patient Journey

Patient journey studies utilize qualitative interviews to explore and confirm hypotheses, establish essential context, and provide perspectives on the disease or condition and medical product. We take an advanced data-driven approach to integrate the patient voice and fully understand the symptoms, impact, and unmet need of the disease.

DIA 2019 Poster

DEMYSTIFYING THE PATIENT’S EXPERIENCE: USE OF PATIENT JOURNEY STUDIES TO GATHER VALUABLE QUALITATIVE INSIGHT INTO THE PATIENT EXPERIENCE

Authors: Stroupe A, Seo C, Uzumcu A, McCarrier K

DOWNLOAD POSTER

Recent Studies

Patient’s Journey Through Acute Myeloid Leukemia (AML): Understanding AML’s Humanistic Impact Through an International Patient-Centric Qualitative Study

The objective of this study is to document patients’ experiences and treatment pathways for acute myeloid leukemia (AML) across Canada, Denmark, and the United Kingdom.

VIEW PRESENTATION

Humanistic Burden of Disease for Patients With Advanced Melanoma in Canada

Metastatic melanoma is a highly aggressive cancer, often striking in the prime of life. This study provides new information directly from advanced melanoma (stage III and IV) patients on how their disease impacts their health-related quality of life (HRQL).

VIEW PUBLICATION

Patient-reported Treatment-related Symptom Burden for Patients with Advanced Melanoma in Canada

Little is known on the impact of emerging treatments for advanced melanoma (stages III and IV) on patients’ functioning and well-being. The objective of this study was to describe the patient-reported treatment-related symptom (TRS) burden in advanced melanoma.

VIEW PUBLICATION

Therapeutic Areas

View a list of therapeutic areas where we have completed patient journey studies.

  • Melanoma

  • Rare Urinary Disorder

  • Acute Myeloid Leukemia

  • Prostate Cancer

  • Neuroendocrine Tumors

  • Hemophilia

  • Cushing’s Disease

  • Premature Ejaculation

  • And More

Browse our publications by therapeutic area